Treatment with ferumoxytol for patients with iron deficiency anemia (IDA) and comorbid gastrointestinal disorders was found to be efficacious and generally well-tolerated in an analysis of a Phase ...

Iron replacement with IV ferumoxytol appears effective and safe for iron-deficient pregnant women with anemia in their second or third trimester, according to study results published in ...

Ferumoxytol consists of a superparamagnetic iron oxide coated with a carbohydrate shell that helps to isolate the bioactive iron from plasma components until the complex enters the macrophages ...

Filing includes results of head-to-head Phase 3 clinical trial evaluating Feraheme compared to ferric carboxymaltose injection Potential approval and launch in the first half of 2018 WALTHAM, Mass ...

Ferumoxytol (Feraheme, AMAG Pharmaceuticals), indicated in the treatment of iron deficiency in chronic kidney disease, is gaining interest as a contrast agent for vascular MRI that not only is ...

Compared to iron sucrose, adjusted odds ratios for anaphylaxis were 8.3 for iron dextran and 3.4 for ferumoxytol, but did not differ significantly for gluconate or ferric carboxymaltose, they noted.

Intravenous (IV) iron use overall is associated with a “very low” risk for anaphylaxis, but iron dextran and ferumoxytol carry an increased risk relative to iron sucrose, according to new research ...

"Ferumoxytol nanozymes—because of their unique catalytic (enzyme-like) activity—offer new and very effective ways to treat ...

Ferumoxytol, a drug already approved for treating anemia, seems to kill not only acute myeloid leukemia (AML) cells, but also the stem cells that give rise to them, according to a research team ...